Drug stocks diverge; AstraZeneca falls on forecast

Drug stocks diverged in early trading early Thursday while shares of AstraZeneca plc slid after the company said it expects revenue to decline in 2010 because of increased generic competition for some of its best-selling products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.